跳转至内容
Merck
CN

U0507

Ultrogel® A4

aqueous ethanol suspension, 60-140 μm (wet bead diameter), exclusion limit 20,000,000 Da, fractionation range 55,000-9,000,000 Da (globular proteins)

别名:

珠状琼脂糖

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

化学文摘社编号:
UNSPSC Code:
12352201
PubChem Substance ID:
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


form

aqueous ethanol suspension

matrix

4% beaded agarose

particle size

60-140 μm (wet bead diameter)

pore size

20,000,000 Da exclusion limit, 55,000-9,000,000 Da fractionation range (globular proteins)

storage temp.

2-8°C

SMILES string

OC[C@H]1O[C@@H](O[C@@H]2[C@@H]3CO[C@H]2[C@H](O)[C@@H](O3)O[C@H]4[C@@H](O)[C@@H](CO)O[C@@H](O[C@@H]5[C@@H]6CO[C@H]5[C@H](O)[C@H](O)O6)[C@@H]4O)[C@H](O)[C@@H](O)[C@H]1O

InChI

1S/C24H38O19/c25-1-5-9(27)11(29)12(30)22(38-5)41-17-8-4-36-20(17)15(33)24(40-8)43-18-10(28)6(2-26)39-23(14(18)32)42-16-7-3-35-19(16)13(31)21(34)37-7/h5-34H,1-4H2/t5-,6-,7+,8+,9+,10+,11+,12-,13+,14-,15+,16-,17-,18+,19+,20+,21-,22+,23+,24+/m1/s1

InChI key

MJQHZNBUODTQTK-WKGBVCLCSA-N

Physical form

预溶胀的琼脂糖微粒溶于含 20% 乙醇的 1M NaCl 中形成的无粉末悬浮液

Other Notes

珠状琼脂糖用于分离高分子量的分子。交联珠状琼脂糖更能耐受变性条件,从而为样本缓冲液和洗脱液的选择提供更多的灵活性。近似的 % 琼脂糖浓度由产品名 (Ultrogel A%) 表示。

Legal Information

Ultrogel is a registered trademark of Pall Corporation


存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

141.8 °F

flash_point_c

61 °C

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Jia Liu et al.
Proceedings of the National Academy of Sciences of the United States of America, 110(17), 6694-6699 (2013-04-10)
Seamless and minimally invasive integration of 3D electronic circuitry within host materials could enable the development of materials systems that are self-monitoring and allow for communication with external environments. Here, we report a general strategy for preparing ordered 3D interconnected
Gianluca Vadalà et al.
Spine, 38(6), E319-E324 (2013-01-18)
Descriptive anatomical study on ovine and human cadaveric lumbar spinal segments. To describe the alternative transpedicular approach to deliver therapeutic agents into intervertebral disc (IVD). The present delivery approach of therapeutic agents (growth factors/cells/hydrogels) within the IVD is through injection
Michael J Lafferty et al.
The Journal of biological chemistry, 288(40), 28524-28534 (2013-08-21)
Elevated triglycerides are associated with an increased risk of cardiovascular disease, and lipoprotein lipase (LPL) is the rate-limiting enzyme for the hydrolysis of triglycerides from circulating lipoproteins. The N-terminal domain of angiopoietin-like protein 4 (ANGPTL4) inhibits LPL activity. ANGPTL4 was